Environmental toxicants in developing countries. by Ostrosky-Wegman, P & Gonsebatt, M E
Environmental Toxicants
in Developing Countries
Patricia Ostrosky-Wegman and Maria E. Gonsebatt
Department of Genetics and Environmental Toxicology, Instituto de
Investigaciones Biomedicas, UNAM, A.P., Mexico
Health effects from environmental toxicants may be a more serious problem in developing
countries compared with developed countries because the problem is potentiated by other
factors: a) the lack of orfailure to enforce regulations, which allows human exposures to genotoxic
agents; b) undernourishment of the lower economic and social classes that comprise the most
exposed populations from industrial and agricultural activities; and c) parasitic infections that
afflict a wide range of populations in both urban and rural areas. Data on the genotoxic effects of
different types of exposures, including environmental exposures (natural and industrial), occupa-
tional exposures, and infections and medical treatments, are presented and discussed with the
point of view that all these factors must be taken into account with respect to regulation and the
protection of human health. Occupational exposures in developing countries are higher than in
developed countries due to lack of stringent regulations, lack of knowledge of the risks involved,
and the negligence of workers. General pollution is another important issue since developed
countries have established strict regulations and risky industrial processes are being exported to
developing countries, along with banned substances and dangerous industrial wastes. It should
be emphasized that stringent regulations in developed countries will not prevent exposures in the
long term because toxic substances that are released into the environment will ultimately reach
all our future generations. - Environ Health Perspect 104(Suppl 3):599-602 (1996)
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Introduction
The scientific community is, or should be,
engaged in very serious considerations of
strategies to urge conservation ofnatural
resources and protection of the environ-
ment. There is a need for better education
of individuals, communities, and busi-
nesses to change the mind-set for resource
conservation and waste reduction tech-
nologies. Although we can separate good
from bad, rich from poor, and developed
from developing countries, the task to
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isolate polluted from unpolluted oceans or
to stop a radioactive cloud that crosses my
backyard is almost impossible.
Unlike much ofbasic research, environ-
mental toxicology has often been instigated
by public policy. Many laws have been
established in the United States, Canada,
Europe, and Japan to mandate toxicity
testing or to require an assessment oftoxic-
ity of environmental pollutants. While
environmental contamination ofair, water,
and soil in developing nations is recognized
as a source ofhealth problems, pollution
controls are ignored. In addition, the exten-
sive agricultural base is associated with
widespread pesticide use and subsequent
contamination beyond points of applica-
tions. Waste disposal practice typically con-
sists ofdumping into rivers, water supplies,
and landfills without proper waste contain-
ment and treatment (1). The problem is
potentiated by other factors such as under-
nourishment of the low-income workers
who, at the same time, are the most exposed
population due to industrial and agricul-
tural activities. Also, parasitic infections
afflict awide range ofpopulations in urban
and rural areas. Individuals with parasitic
infections might be more susceptible to
toxicants. Moreover, since some of these
infections are recurrent, medical treatment
is prescribed (sometimes autoprescribed)
more often in the lifetime ofthese individ-
uals. The effect between medical treatment
and exposure to contaminants is unknown.
Data from previous and ongoing
studies investigating the genotoxic and
cytotoxic effects ofdifferent types ofexpo-
sures, including environmental and occu-
pational exposures, infections, and medical
treatments, are presented and discussed.
Cytotoxicity and Genotoxicity
in Parasitic Infections
Parasitic infections affect more than 200
million people worldwide. Chronic infec-
tion and inflammation have been impli-
cated in the development ofhuman cancers
(2). We have evaluated the frequency of
mutations at the HPRTlocus and the lym-
phocyte proliferation kinetics (LPK) in
individuals infected with Taenia solium
cysts in the brain (neurocysticercosis).
These patients showed higher frequencies
of mutations together with LPK retarda-
tion compared with non-infected controls.
After a 15-day treatment with praziquantel
(PZQ), the drug ofchoice, both parameters
returned to control values (3). A reduction
in chromosomal damage was observed in
schistosomiasis patients after treatment
with PZQ (W Anwar, personal communi-
cation), indicating that the infections by
themselves were promoting genetic damage
in hosts (3). In agreementwith these obser-
vations, lymphocyte cultures from infected
pigs showed higher proportions ofpoly-
ploid cells before the PZQ treatment (4).
A time-dependent increase ofsister chro-
matid exchanges after inoculation with
T solium eggs and an increased lymphocyte
proliferation for 6 to 8 weeks post infec-
tion, followed by an impaired proliferation
after this period, were also observed (5).
There is also evidence for lymphocyte-
function impairment caused by cestodes: a
depression of cellular response in mice
infected by T. taeniaeformis could be due
to factors produced by the parasite (6). A
factor secreted by T solium cysticercus was
isolated; this factor depressed 3H-thymi-
dine uptake by T lymphocytes in vitro (7).
These results are in agreement with the
immunosuppression induced in mice and
pigs (8-10) and in humans (11) infected
with T solium metacestodes.
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In Brazil, Cetron et al. (12) studied
the humoral and cell-mediated immune
response in 70 individuals (symptomatic
and nonsymptomatic) infected with Trypa-
nosoma cruzi and in 30 noninfected indi-
viduals. Peripheral blood mononuclear
cells from infected individuals showed
lower proliferative response to phytohemag-
glutinin (PHA), although the difference
was not statistically significant. Definitive
conclusions regarding the magnitude ofthe
PHA responses among the groups were not
possible, given the 5-day harvest time
point. Patients with symptomatic Chagas'
disease, which is caused by this parasite,
had significantly decreased cellular response
to T. cruzi lysate compared with those of
the undetermined group (12).
Genotoxicity of
Antiparasitic Drugs
Several chemical agents currently in use to
treat parasitic infections are known or sus-
pected mutagens/carcinogens (13). The
metabolic activation ofsome ofthese drugs
generates genotoxic metabolites. Since
metabolic capacities vary among individu-
als, genotoxic effects may also vary among
treated individuals.
Niclosamide is a drug used to treat tape-
worm intestinal infections. Experiments in
our laboratory using the Salmonella typhi-
murium microsomal test system showed
that niclosamide induced frameshift muta-
tions following metabolic activation.
Mutagenic activity was also detected in the
urine of mice after oral administration of
the drug (14). Clastogenic damage was
observed after S9 metabolic activation in
vitro, and a significant increase ofchromo-
somal aberrations was found in lympho-
cytes from three ofthe five patients treated
with niclosamide (15).
In the case ofmetronidazole (MTZ), an
imidazole derivative which is the drug of
choice for the treatment of Trichomona
vaginalis, Entoamoeba histolitica, and
Giardia lambia, several studies were con-
ducted in animal models and in humans.
Treated Pelibuey sheep showed a signi-
ficant increase in the HPRTvariant fre-
quency (Vf) (16). The highest Vf were
found in the animals with the highest
steady-state MTZ in plasma. An inverse
relationship between the Vfand drug elim-
ination was found. The fact that the ani-
mals with the lowest elimination rates of
MTZ had increased gene mutations indi-
cated that differences in pharmacokinetics
constitute one potential mechanism of
genotoxic susceptibility (16).
We studied the effects of therapeutic
doses of MTZ in 12 healthy nonsmoker
male volunteers, who were 18 to 25 years
old and weighed 55 to 65 kg. The fre-
quency ofchromosome aberrations and the
LPK in lymphocyte cultures were com-
pared before and after treatment. Increased
frequencies of chromosome breaks with
interindividual variation were observed.
Also, grouped data revealed a marginal
significant effect on mitotic index (MI),
while this increment was highly significant
in 3 ofthe 12 volunteers. At the same time,
a faster LPKwas observed in 10 individuals
after treatment. In agreement with the dif-
ferent MTZ pharmacokinetics observed in
sheep, different concentrations ofMTZ in
the plasma ofthese volunteers were found.
Since MTZ is metabolized by the P450
enzymes, particularly by that encoded in
the CYPIAI locus which is polymorphic
[G Elizondo, manuscript in preparation;
(17)], individual differences observed
could be due to differences at this level.
Genotoxicity and Malnutrition
Malnourishment and undernourishment
constitute important factors for considera-
tion when monitoring studies are per-
formed. It has been demonstrated that
malnourished children showed more
genetic damage in their lymphocytes than
well-nourished ones (18-20). In rats main-
tained under an isocaloric and hypopro-
teinic diet, an induction of P450 liver
enzymes involved in the metabolism of
several mutagens was observed J Espinosa,
personal communication).
Environmental Exposure
Xenobiotic exposure generates concern in
developing countries, especially because the
levels of exposure are often several times
higher than in developed nations. Lung
concentrations ofheavy metals such as Cd,
Cu, Co, Ni, and Pb found in autopsy cases
in Mexico City during the 1980s were
higher than levels found in cases from the
1950s. A possible explanation for this
increase is the growing number ofvehicles
and industries operating in Mexico City
(T Fortoul, personal communication).
Arsenic, a human carcinogen, is mobi-
lized from its natural sources by many
activities such as contamination ofwater,
smelting of metals, combustion of fossil
fuels, the use ofpesticides or herbicides
containing arsenic, and more recently, by
the semiconductor industry. Although ear-
lier studies indicated occupational risk in
smelter workers (21), the genotoxicity of
inorganic arsenic in exposed groups has
been a matter ofdebate (22). However, a
recent study in individuals with lifetime
exposure to approximately 300 mg/l of
arsenic in their drinking water showed ele-
vated frequencies ofchromatid-type aber-
rations and of micronuclei in buccal and
urothelial cells. Genetic damage in males
appears to be related to their methylation
capacities (ME Gonsebatt, manuscript in
preparation). Also, increased single-strand
DNA breaks were detected in blood lym-
phocytes using the single cell electrophoresis
assay (23).
Personnel working at landfills are at
risk, especially when they handle toxic
materials with little protection. Although
blood lead, urinary mercury, hair cadmium,
and blood and urinary phenol levels were
at control levels, a significantly increased
level ofchromosomal damage was detected
among a group ofhigh-riskworkers. More-
over, this damage was found to increase
with exposure time (24).
Lymphocyte Proliferation
Studies
The methods of cellular replication, e.g.,
labeling, mitotic, and replication indexes,
are used as indicators of toxicity; these
methods have given valuable information
on the mechanisms of action of certain
drugs (25,26) and have been shown to be
affected by medical treatments and envi-
ronmental exposures. While parasitic infec-
tions impair lymphocyte proliferation,
MTZ treatment enhanced it. Chronic
exposure to arsenic via drinking water
inhibited lymphocyte stimulation and pro-
liferation (27,28), especially in those indi-
viduals showing arsenic skin lesions;
squamous cell carcinoma is one type of
skin cancer frequently observed in these
individuals and is the only type ofcancer
with a nonviral origin that is associated
with immunosupression (29). Although
these indexes are not specific parameters of
immune impairment, they have been shown
to be sensitive parameters in our human
monitoring studies as a first approach to
evaluate immunotoxic effects (Table 1).
Conclusions
Due to its rapid industrialization, Latin
America is undergoing socioeconomic
changes and an increase in diseases related
to development. Human monitoring is
therefore especially relevant in developing
countries. While monitoring studies in
developed countries showed that workers
tend to take protective measures, workers
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Table 1. Genotoxic effects in individuals with exposure to xenobiotics.
Riskfactor Genotoxicity LPK References
Parasitic infection
Neurocysticercosis Increased Vf in HPRT (-)a (3)
Antiparasitic drugs
Niclosamide CA (15)
Metronidazole CAb (W)C (17)
Environmental exposure C d
Inorganic arsenic CA", MN I SCGE -)a (23,28)
Toxic waste CA No effect (24)
Abbreviations: LPK, lymphocyte proliferation kinetics; Vf, variation frequency; CA, chromosome aberrations; MN,
micronuclei; SCGE, single cell gel electrophoresis. 'Inhibition or impairment. hG Elizondo, unpublished data.
cEnhancement.dME Gonsebatt, unpublished data.
in Latin America still are, in many cases,
not aware ofhealth problems related to
chemical and radiation exposures. Develop-
ing countries are also becoming disposal
sites for industrialized nations whose regula-
tions and laws prohibit the disposal ofsome
types ofwastes. Here is where our findings
must impact most. We must continue our
efforts in working with government, busi-
ness, and people to develop legislation that
will protect natural resources, diminish
exposure to toxicants (environmental or
occupational), and improve education in
the importance ofprevention ofinfectious
and exposure-related diseases. Manychanges
are required, not just in the developed
nations but globally. "Think globally, act
locally" applies very well to the spirit of
this presentation. Ifwe want to protect the
future ofour world and our species, inter-
national policies, as well as local ones,
should be established and experts in the
field should be prepared, especially in
developingcountries.
The acquisition ofnew technologies,
industries, or products should have the
same safety standards in developed and
developing countries because the genotoxic
or immunotoxic effects we observed in
highly exposed individuals are examples of
what can be expected when regulations are
avoided or ignored. International collabora-
tive studies should be encouraged to moni-
tor high-risk groups using the approaches
that have proven to be successfil and devel-
oping new ways to identify different levels
ofexposure and their effects. In addition,
these studies could help create awareness in
the exposed groups and in their communi-
ties. Good examples are the arsenic study
mentioned previously, which was a joint
project between the United States and
Mexico (unpublished data), and the bio-
monitoring study on occupational expo-
sure to ethylene oxide performed between
Brazilian and European scientists (30).
Finally, we should keep in mind astate-
ment made by Malling and Valcovic indi-
cating that "the present generation is only a
caretaker ofthe human genome offuture
generations" (31).
REFERENCES
1. Sullivan JB, Krieger, GR. Introduction to hazardous materials
toxicology. In: Hazardous Materials Toxicology (Sullivan JB,
Krieger GR, eds). Baltimore, MD:Williams & Wilkins,
1992;2-8.
2. IARC. IARC Monograph on the Evaluation ofCarcinogenic
Risks to Humans. Vof61: Schistosomes, Liver Flukes and
Helicobacterpylori. Lyon:International Agency for Research on
Cancer, 1994;39-42.
3. Montero R, FlisserA, Madrazo I, Cuevas C, Ostrosky-Wegman
P. Mutation at the HPRTlocus in patients with neurocysticer-
cosis treatedwith praziquantel. Mutat Res 305:181-188 (1994).
4. Flisser A, Gonzilez D, Plancarte A, Ostrosky P, Montero R,
Stephano A, Correa D. Praziquantel treatment of brain and
musde Taenia solium cysticercosis II. Parasitol Res 76:640-642
(1990)
5. Herrera LA, Santiago P, Rojas G, Salazar PM, Tato P, Molinari
JL, Schiffman D,Ostrosky-Wegman P. Immune response impair-
ment, genotoxicity and morphological transformation induced by
Taeniasoimmetacestode. Mutat Res 305:223-228 (1994).
6. Letonja T, Hammerberg C, Schuring G. Evaluation ofspleen
lymphocyte responsiveness to a T-cell mitogen during early
infection with larval Taenia taeniaeformis. Parasitol Res
73:265-270 (1987).
7. Molinari JL, Tato P, Reynoso OA, Cazares JML. Depressive
effect of a Tamnia solium cysticercus factor on cultured human
lymphocytes stimulated with phytohaemagglutinin. Ann Trop
Med Parasitol 84:205-208 (1990).
8. Willms K, Merchant M, Arcos L, Sealy M, Diaz S, Diaz de
Le6n L. Immunopathology ofcysticercosis. In: Molecules, Cells
and Parasites in Immunology (Larralde C, Willms K, Ortiz L,
Seal M, eds). NewYorkAcademic Press, 1980;145-162.
9. Tato P, Valles Y, Rolon R, MolinariJL. Effects ofimmunization
in immunodeppressed hogs naturallyparasitized with Cysticercus
cellulosae. RevLatinoam Microbiol 29:67-71 (1987).
10. Molinari JL, Tato P, Valles Y. Helper T lymphocyte depressed
by Cysticercus cellulosac in immunized and control hogs. Rev
Latinoam Microbiol 29:293-300 (1987).
11. FlisserA, Woodhouse E, Larralde C. Human cysticercosis: anti-
gens, antibodies and nonresponders. Clin Exp Immunol
39:27-37 (1980)
12. Cetron MS, Basilio FP, MoraesAP, SousaAQ, PaesJN, Kahn SJ,
Wener MH, Van Voorhis WC. Humoral and cellular immune
response of adults from northeastern Brazil with chronic
Trypanosoma cruzi infection: depressed cellular immune
response to T u anti en among Chagas' disease patients with
symptomatic versus indeterminate infection. Am J Trop Med
Hyg49:370-382 (1993).
13. Gentile JM, Ostrosky-Wegman P. Preface. Mutat Res 305:117
(1994).
14. Cortinas de Nava C, Espinosa J, Garcia L, Zapata AM,
Martinez E. Mutagenicity ofantiamebic and antihelmintic
drugs in the Salmonella typhimurium microsomal test system.
Mutat Res 117:79-91 (1980).
15. Ostrosky-Wegman P, Garcfa G, Montero R, Perez Romero B,
Alvarez Chac6n R, Cortinas de Nava C. Susceptibility to geno-
toxic effects ofniclosamide in human peripheral lymphocytes
exposed in vitroand in vivo. Mutat Res 173:81-87 (1986).
16. Ostrosky-Wegman P, Lares Asseff I, Santiago P, Elizondo G,
Montero R. Metronidazole hprtmutation induction in sheep
and the relationship with its elimination rate. Mutat Res
307:253-259 (1994).
17. Elizondo G, Montero R, Herrera JE, Hong E, Ostrosky-
Wegman P. Lymphocyte proliferation kinetics and sister-chro-
matid exchanges in individuals treated with metronidazole.
Mutat Res 305:133-137 (1994).
18. Armendares S, Salamanca F, Fran S. Chromosome abnormali-
ties in severe protein calorie malnutrition. Nature 232:271-273
(1971).
Environmental Health Perspectives * Vol 104, Supplement 3 * May 1996 601OSTROSKY-WEGMAN AND GONSEBATr
19. Ortiz R, Campos C, Gomez JL, Espinoza M, Ramos-Motilla
M, Betancourt M. Sister-chromatid exchange (SCE) and cell
proliferation in lymphocytes from infected and non-infected
children with severe protein calorie malnutrition (PCM).
Mutat Res 312:33-37 (1994).
20. Betancourt M, Ortiz R, Gonzilez C, Perez P, Cortes L,
Rodrifez L, Villasefior L. Assessment ofDNA damage in leuko-
cytes rom infected and malnourished children by single cell gel
eletrophoresis/comet assay. Mutat Res 331:65-77 (1995).
21. Nordenson I, Beckman G, Beckman L, Nordstrom S.
Occupational and environmental risks in and around a smelter
in northern Sweden. II. Chromosomal aberrations in workers
exposed to arsenic. Hereditas 88:47-50 (1978).
22. U.S. EPA. Health Assessment Document for InorganicArsenic.
Final Report. EPA 600/8-83-021F. Research Triangle Park, NC:
U.S. Environmental Protection Agency, 1984.
23. Valverde M. Study ofa population exposed to chronic hydro-
arsenicism using the single cell electrophoresis assay (SCGE)
[Graduate Thesis]. Faculty ofSciences, UNAM. Mexico 1995.
24. Gonsebatt ME, Salazar AM, Montero R, Diaz Barriga F, Yifiez
L, Gomez H, Ostrosky-Wegman P. Genotoxic monitoring of
workers at a hazardous waste disposal site in Mexico. Environ
Health Perspect 103(Suppl 1):111-113 (1995).
25. Rojas E, Herrera LA, Sordo M, Gonsebatt ME, Rodriguez R,
Ostrosky-Wegman P. Mitotic index and cell proliferation
kinetics for the identification of antineoplastic activity.
Anticancer Drugs 4:637-640 (1993).
26. Montero R, Gonsebatt ME, Gerson R, Rojas E, Herrera LA,
Ostrosky-Wegman P. AS-101: a modulator of in vitro T-cell
proliferation. Anticancer Drugs 4:351-354 (1993).
27. Ostrosky-Wegman P, Gonsebatt ME, Montero R, Vega L,
Barba H, Espinosa J, Palao A, Cortinas C, Garcia-Vargas G, del
Razo LM, Cebriin M. Lymphocyte proliferation kinetics and
genotoxic findings in a pilot study on individuals chronically
exposed to arsenic in Mexico. Mutat Res 250:477-482 (1991).
28. Gonsebatt ME, Vega L, Montero R, Garcia Vargas G, Del
Razo LM, Albores A, Cebrian ME, Ostrosky-Wegman P.
Lymphocyte replicating ability in individuals exposed to arsenic
via drinking water. Mutat Res 313:293-299 (1994).
29. IARC. Consensus report. In: Mechanisms ofCarcinogenesis in
Risk Identification. IARC Sci Publ 116 (Vainio H, Magee P,
McGregor D, McMichael AJ, eds). Lyon:International Agency
for Research on Cancer 1992;9-54.
30. Ribeiro LR, Salvadori DMF, Rios ACC, Costa SL, Tates AD,
Tornqvist M, Natarajan AT. Biological monitoring ofworkers
occupationally exposed to ethylene oxide. Mutat Res 313:81-87
(1994).
31. Brusick D. Principles of Genetic Toxicology. New
York:Plenum Press. 1984;ix.
602 Environmental Health Perspectives * Vol 104, Supplement 3 * May 1996